Molecular mechanisms used by chaperones to reduce the toxicity of aberrant protein oligomers
暂无分享,去创建一个
C. Dobson | C. Roodveldt | H. Kampinga | F. Chiti | Mark R. Wilson | B. Mannini | Sarah Meehan | S. Campioni | C. Cecchi | R. Cascella | A. Relini | M. V. van Waarde-Verhagen | A. Penco | M. Zampagni | M. Boninsegna
[1] F. Chiti,et al. A comparison of the biochemical modifications caused by toxic and non-toxic protein oligomers in cells , 2011, Journal of cellular and molecular medicine.
[2] Andreas Bracher,et al. Molecular chaperones in protein folding and proteostasis , 2011, Nature.
[3] H. Kampinga,et al. Identification of the Drosophila Ortholog of HSPB8 , 2010, The Journal of Biological Chemistry.
[4] Glyn L. Devlin,et al. The Interaction of αB-Crystallin with Mature α-Synuclein Amyloid Fibrils Inhibits Their Elongation , 2010, Biophysical journal.
[5] Fabrizio Chiti,et al. A causative link between the structure of aberrant protein oligomers and their toxicity. , 2010, Nature chemical biology.
[6] C. Dobson,et al. Chaperone proteostasis in Parkinson's disease: stabilization of the Hsp70/α‐synuclein complex by Hip , 2009, The EMBO journal.
[7] F. Hartl,et al. The role of molecular chaperones in human misfolding diseases , 2009, FEBS letters.
[8] R. Morimoto,et al. Biological and chemical approaches to diseases of proteostasis deficiency. , 2009, Annual review of biochemistry.
[9] R. Morimoto,et al. Proteotoxic stress and inducible chaperone networks in neurodegenerative disease and aging. , 2008, Genes & development.
[10] M. Stefani,et al. Replicating neuroblastoma cells in different cell cycle phases display different vulnerability to amyloid toxicity , 2008, Journal of Molecular Medicine.
[11] Mark R. Wilson,et al. Protease activation of alpha2-macroglobulin modulates a chaperone-like action with broad specificity. , 2008, Biochemistry.
[12] C. Dobson,et al. The extracellular chaperone clusterin influences amyloid formation and toxicity by interacting with prefibrillar structures , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[13] Fabrizio Chiti,et al. Prevention of amyloid‐like aggregation as a driving force of protein evolution , 2007, EMBO reports.
[14] C. Dobson,et al. Protein misfolding, functional amyloid, and human disease. , 2006, Annual review of biochemistry.
[15] J. Weissman,et al. Molecular Chaperones and Protein Quality Control , 2006, Cell.
[16] Jimena Weibezahn,et al. Novel insights into the mechanism of chaperone-assisted protein disaggregation , 2005, Biological chemistry.
[17] M. Rybchyn,et al. The acute phase protein haptoglobin is a mammalian extracellular chaperone with an action similar to clusterin. , 2005, Biochemistry.
[18] Robert E. Cohen,et al. Proteasomes and their kin: proteases in the machine age , 2004, Nature Reviews Molecular Cell Biology.
[19] D. Selkoe. Folding proteins in fatal ways , 2003, Nature.
[20] T. Morgan,et al. Vaccination with soluble Aβ oligomers generates toxicity‐neutralizing antibodies , 2001, Journal of neurochemistry.
[21] L. Fumagalli,et al. Role of α2‐macroglobulin in regulating amyloid β‐protein neurotoxicity: protective or detrimental factor? , 2001 .
[22] H. Kampinga,et al. In Vivo Chaperone Activity of Heat Shock Protein 70 and Thermotolerance , 1999, Molecular and Cellular Biology.
[23] S. Paul,et al. α2‐Macroglobulin Attenuates β‐Amyloid Peptide 1–40 Fibril Formation and Associated Neurotoxicity of Cultured Fetal Rat Cortical Neurons , 1998 .
[24] P. May,et al. Clusterin (Apo J) Protects Against In Vitro Amyloid‐β(1–40) Neurotoxicity , 1996 .
[25] Steven A. Johnson,et al. Clusterin (apoJ) Alters the Aggregation of Amyloid β-Peptide (Aβ1-42) and Forms Slowly Sedimenting Aβ Complexes That Cause Oxidative Stress , 1995, Experimental Neurology.
[26] M. Wilson,et al. Clusterin binds by a multivalent mechanism to the Fc and Fab regions of IgG. , 1992, Biochimica et biophysica acta.
[27] Mark R. Wilson,et al. Potential roles of abundant extracellular chaperones in the control of amyloid formation and toxicity. , 2008, Molecular bioSystems.